US Patent 8846603 NPP1 fusion proteins
Patent 8846603 was granted and assigned to Synageva BioPharma on September, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 6 Nov, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Alex J. Harvey0
Anthony Quinn0
Zhinan Xia0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08846603 NPP1 fusion proteins US Patent 8846603 NPP1 fusion proteins
Infobox
Patent Number
08846603
Patent Number
8846603
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 27 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08846603 NPP1 fusion proteins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08846603
Date of patent
September 30, 2014
Patent application number
13583973
Date Filed
March 11, 2011
Patent primary examiner
Find more entities like US Patent 8846603 NPP1 fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
